CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 172 filers reported holding CARA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,902 | -45.8% | 8,275 | -8.8% | 0.00% | -100.0% |
| Q2 2023 | $25,668 | +128240.0% | 9,070 | +117.3% | 0.00% | 0.0% |
| Q1 2023 | $20 | -89.5% | 4,174 | -76.4% | 0.00% | -87.5% |
| Q4 2022 | $191 | -99.8% | 17,717 | +43.4% | 0.01% | +300.0% |
| Q3 2022 | $116,000 | +87.1% | 12,354 | +82.2% | 0.00% | +100.0% |
| Q2 2022 | $62,000 | -15.1% | 6,781 | +12.2% | 0.00% | 0.0% |
| Q1 2022 | $73,000 | -21.5% | 6,044 | -20.8% | 0.00% | -50.0% |
| Q4 2021 | $93,000 | -66.4% | 7,627 | -57.4% | 0.00% | -71.4% |
| Q3 2021 | $277,000 | +544.2% | 17,905 | +498.6% | 0.01% | +600.0% |
| Q2 2021 | $43,000 | -49.4% | 2,991 | -23.8% | 0.00% | 0.0% |
| Q1 2021 | $85,000 | +44.1% | 3,923 | +1.0% | 0.00% | -50.0% |
| Q4 2020 | $59,000 | -80.8% | 3,885 | -84.0% | 0.00% | -33.3% |
| Q3 2020 | $308,000 | +190.6% | 24,251 | +290.5% | 0.00% | -25.0% |
| Q2 2020 | $106,000 | +1.9% | 6,211 | -4.2% | 0.00% | -55.6% |
| Q4 2019 | $104,000 | +5100.0% | 6,481 | +6381.0% | 0.01% | – |
| Q3 2019 | $2,000 | -75.0% | 100 | -75.4% | 0.00% | – |
| Q1 2019 | $8,000 | +700.0% | 407 | +784.8% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 46 | -50.5% | 0.00% | – |
| Q1 2018 | $1,000 | -92.3% | 93 | -86.7% | 0.00% | -100.0% |
| Q1 2017 | $13,000 | -18.8% | 701 | -58.6% | 0.00% | -50.0% |
| Q4 2016 | $16,000 | -66.0% | 1,693 | -70.2% | 0.00% | -60.0% |
| Q3 2016 | $47,000 | +135.0% | 5,680 | +77.7% | 0.01% | +66.7% |
| Q1 2016 | $20,000 | +900.0% | 3,197 | +3301.1% | 0.00% | – |
| Q4 2015 | $2,000 | -95.3% | 94 | -96.9% | 0.00% | -100.0% |
| Q3 2015 | $43,000 | +975.0% | 3,037 | +899.0% | 0.00% | – |
| Q2 2015 | $4,000 | -66.7% | 304 | -75.0% | 0.00% | -100.0% |
| Q1 2015 | $12,000 | -36.8% | 1,217 | -36.8% | 0.00% | -50.0% |
| Q4 2014 | $19,000 | +1800.0% | 1,927 | +1176.2% | 0.00% | – |
| Q3 2014 | $1,000 | -98.5% | 151 | -95.9% | 0.00% | -100.0% |
| Q1 2014 | $68,000 | – | 3,665 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |